164 related articles for article (PubMed ID: 21193909)
1. CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression.
Zloza A; Jagoda MC; Lyons GE; Graves MC; Kohlhapp FJ; O'Sullivan JA; Lacek AT; Nishimura MI; Guevara-Patiño JA
Cancer Immunol Immunother; 2011 Feb; 60(2):291-7. PubMed ID: 21193909
[TBL] [Abstract][Full Text] [Related]
2. Truncated form of TGF-βRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice.
Ishigame H; Mosaheb MM; Sanjabi S; Flavell RA
J Immunol; 2013 Jun; 190(12):6340-50. PubMed ID: 23686479
[TBL] [Abstract][Full Text] [Related]
3. Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta.
Szczepanik M; Bryniarski K; Tutaj M; Ptak M; Skrzeczynska J; Askenase PW; Ptak W
Immunology; 2005 May; 115(1):42-54. PubMed ID: 15819696
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
Zhang L; Yu Z; Muranski P; Palmer DC; Restifo NP; Rosenberg SA; Morgan RA
Gene Ther; 2013 May; 20(5):575-80. PubMed ID: 22972494
[TBL] [Abstract][Full Text] [Related]
5. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
[TBL] [Abstract][Full Text] [Related]
6. Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8
Zhang Q; Helfand BT; Carneiro BA; Qin W; Yang XJ; Lee C; Zhang W; Giles FJ; Cristofanilli M; Kuzel TM
Eur Urol; 2018 May; 73(5):648-652. PubMed ID: 29275833
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.
Cattley RT; Lee M; Boggess WC; Hawse WF
J Biol Chem; 2020 Jun; 295(24):8236-8251. PubMed ID: 32358062
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.
Papadakis KA; Krempski J; Reiter J; Svingen P; Xiong Y; Sarmento OF; Huseby A; Johnson AJ; Lomberk GA; Urrutia RA; Faubion WA
Am J Physiol Cell Physiol; 2015 Mar; 308(5):C362-71. PubMed ID: 25472963
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory role of CD8alpha in the veto effect.
Asiedu C; Meng Y; Wang W; Huang Z; Contreras JL; George JF; Thomas JM
Transplantation; 1999 Feb; 67(3):372-80. PubMed ID: 10030281
[TBL] [Abstract][Full Text] [Related]
11. The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells.
Quatromoni JG; Suzuki E; Okusanya O; Judy BF; Bhojnagarwala P; Venegas O; Eruslanov E; Predina JD; Albelda SM; Singhal S
BMC Immunol; 2013 Jul; 14():30. PubMed ID: 23865808
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity.
Filippi CM; Juedes AE; Oldham JE; Ling E; Togher L; Peng Y; Flavell RA; von Herrath MG
Diabetes; 2008 Oct; 57(10):2684-92. PubMed ID: 18689691
[TBL] [Abstract][Full Text] [Related]
14. Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3.
McKarns SC; Schwartz RH
J Immunol; 2005 Feb; 174(4):2071-83. PubMed ID: 15699137
[TBL] [Abstract][Full Text] [Related]
15. Priming with very low-affinity peptide ligands gives rise to CD8(+) T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression.
O'Sullivan JA; Zloza A; Kohlhapp FJ; Moore TV; Lacek AT; Dulin NO; Guevara-Patiño JA
Cancer Immunol Immunother; 2011 Nov; 60(11):1543-51. PubMed ID: 21681376
[TBL] [Abstract][Full Text] [Related]
16. Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody.
Terabe M; Ambrosino E; Takaku S; O'Konek JJ; Venzon D; Lonning S; McPherson JM; Berzofsky JA
Clin Cancer Res; 2009 Nov; 15(21):6560-9. PubMed ID: 19861451
[TBL] [Abstract][Full Text] [Related]
17. Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle.
Zhang Q; Yang XJ; Kundu SD; Pins M; Javonovic B; Meyer R; Kim SJ; Greenberg NM; Kuzel T; Meagher R; Guo Y; Lee C
Mol Cancer Ther; 2006 Jul; 5(7):1733-43. PubMed ID: 16891459
[TBL] [Abstract][Full Text] [Related]
18. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attrition.
Bhadra R; Moretto MM; Castillo JC; Petrovas C; Ferrando-Martinez S; Shokal U; Leal M; Koup RA; Eleftherianos I; Khan IA
J Clin Invest; 2014 Jun; 124(6):2441-55. PubMed ID: 24762437
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
